Conjunctival macrophage-mediated influence of the local and systemic immune response after corneal herpes simplex virus-1 infection

Immunology

Volumn 107, Issue 1, 2002, Pages 118-128

  Bauer, Dirk ^a,c   Schmitz, Andreas ^a   Van Rooijen, Nico ^b   Steuhl, Klaus Peter ^a   Heiligenhaus, Arnd ^a,c  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c ST FRANZISKUS HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLODRONIC ACID; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; LIPOSOME; MESSENGER RNA; NEUTRALIZING ANTIBODY; PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CELL CULTURE; CELL FUNCTION; CELLULAR IMMUNITY; CONJUNCTIVA; CONTROLLED STUDY; CORNEA; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DELAYED HYPERSENSITIVITY; DEPLETION; FEMALE; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; IMMUNOMODULATION; LYMPH NODE; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBMANDIBULAR GLAND; SUPERNATANT; TH1 CELL; TH2 CELL;

ANIMALS; ANTIBODIES, VIRAL; CONJUNCTIVA; CORNEA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPESVIRUS 1, HUMAN; HYPERSENSITIVITY, DELAYED; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; KERATITIS, HERPETIC; LYMPH NODES; MACROPHAGES; MICE; MICE, INBRED BALB C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TH1 CELLS; TH2 CELLS;

EID: 0036379763     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2002.01477.x     Document Type: Article

References (46)

1. Hendricks RL, Tumpey TM, Finnegan A. IFN-gamma and IL-2 are protective in the skin but pathologic in the cornea of HSV-1-infected mice. J Immunol 1992; 149:3023-8.
2. Niemialtowski MG, Rouse BT. Phenotypic and functional studies on ocular T cells during herpetic infections of the eye. J Immunol 1992; 148:1864-70.
3. Niemialtowski MG, Rouse BT. Predominance of Th1 cells in ocular tissue during herpetic stromal keratitis. J Immunol 1992; 149:3035-9.
4. + Vβ8+ T cells mediate herpes stromal keratitis. Curr Eye Res 1994; 13:711-6.
5. Tang Q, Chen W, Hendricks RL. Proinflammatory functions of IL-2 in herpes simplex virus corneal infection. J Immunol 1997; 258:1275-83.
6. Babu JS, Kanangat S, Rouse BT. T cell cytokine mRNA expression during the course of the immunopathologic ocular disease herpetic stromal keratitis. J Immunol 1995; 154:4822-9.
7. + T-cell type 1 and type 2 cytokines in the HSV-1 infected cornea. Graefe's Arch Clin Exp Ophthalmol 1999; 237:399-406.
8. Tumpey TM, Elner VM, Chen SH, Oakes JE, Lausch RN. Interleukin-10 treatment can suppress stromal keratitis induced by herpes simplex virus type 1. J Immunol 1994; 153:2258-65.
9. Tumpey TM, Chen SH, Oakes JE, Lausch RN. Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea. J Virol 1996; 70:898-904.
10. Thomas J, Gangappa S, Kanangat S, Rouse BT. On the essential involvement of neutrophils in the immunopathologic disease herpetic stromal keratitis. J Immuno 1997; 158:1383-91.
11. Lausch RN, Kleinschrodt WR, Monteiro C, Kayes SG, Oakes JE. Resolution of HSV cornea infection in the absence of delayed-type hypersensitivity. Invest Ophthalmol Vis Sci 1985; 26:1509-15.
12. Inoue Y, Oh JO, Minasi P. Protective effect of anti-glycoprotein D antibody on herpetic chorioretinitis in newborn rabbits. Curr Eye Res 1991; 10 (Suppl.):159.
13. Staats HF, Lausch RN. Cytokine expression in vivo during murine herpetic keratitis: effect of protective antibody therapy. J Immunol 1993; 151:277-83.
14. Van Klink F, Taylor WM, Alizadeh H, Jager MJ, Van Rooijen N, Niederkorn JY. The role of macrophages in Acanthamoeba keratitis. Invest Ophthalmol Vis Sci 1996; 37:1271-81.
15. Bauer D, Mrzyk S, van Rooijen N, Steuhl KP, Heiligenhaus A. Macrophage-depletion influences the course of murine HSV-1 keratitis. Curr Eye Res 2000; 20:45-53.
16. Cheng H, Tumpey TM, Staats HF, van Rooijen N, Oakes JE, Lausch RN. Role of macrophages in restricting herpes simplex virus type 1 growth after ocular infection. Invest Ophthalmol Vis Sci 2000; 41:1402-9.
17. Hayashi K, Kurata T, Morishima T, Nassery T. Analysis of the inhibitory effect of peritoneal macrophages on the spread of herpes simplex virus. Infect Immun 1980; 28:350-8.
18. Sit MF, Tenney DJ, Rothstein JL, Morahan PS. Effect of macrophage activation on resistance of mouse peritoneal macrophages to infection with herpes simplex virus type 1 and 2. J General Virol 1988; 69:1999-2010.
19. Van Rooijen N, Sanders A. Elimination, blocking, and activation of macrophages: three of a kind? J Leukoc Biol 1997; 62:702-9.
20. Paludan SR. Interleukin-4 and interferon-γ: the quintessence of a mutual antagonistic relationship. Scand J Immunol 1998; 48:459-68.
21. Qian Q, Jutila MA, van Rooijen N, Cutler JE. Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis. J Immunol 1994; 152:5000-8.
22. Van Rooijen N, Sanders A. Liposome-mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Meth 1994; 174:83-93.
23. Claassen I, van Rooijen N, Claassen E. A new method for removal of mononuclear phagocytes from heterogenous populations in vitro, using the liposome-mediated macrophage 'suicide' technique. J Immunol Meth 1990; 134:153-61.
24. Matsuda A, Tagawa Y, Yatsuda H, Nishihira J. Expression of macrophage migration inhibitory factor in corneal wound healing in rats. Invest Ophthalmol Vis Sci 1997; 38:1555-62.
25. Bauer D, Mrzyk S, van Rooijen N, Steuhl KP, Heiligenhaus A. Incidence and severity of herpetic stromal keratitis: impaired by the depletion of lymph node macrophages. Exp Eye Res 2001; 72:261-9.
26. Heiligenhaus A, Berra A, Dutt JE, Zhao TZ, Wells PA, Foster CS. T-cell-induced prevention of HSV-1 keratitis by immunization with the synthetic peptide of glycoprotein D. Ophthalmologe 1994; 91:608-16.
27. Steinmuller C, Steinhoff G, Bauer D et al. Analysis of leukocyte activation during acute rejection of pulmonary allografts in noninfected and cytomegalovirus-infected rats. J Leukoc Biol 1997; 61:40-9.
28. Van Snick J, Cayphas S, Fink A, Uyttenhove C, Coulie P, Simpson R. Purification and NH2-terminal amino acid sequence of a new T cell derived lymphokine with growth factor activity for B-cell. Proc Natl Acad Sci USA 1986; 83:9679-83.
29. Jayaraman S, Heiligenhaus A, Rodriguez A, Soukiasian S, Dorf ME, Foster CS. Exacerbation of murine herpes simplex virus-mediated stromal keratitis by Th2 type T cells. J Immunol 1993; 151:5777-89.
30. Rouse BT. Role of adaptive immune defense mechanisms in Herpes simplex resistance. In: Rouse BT, Lopez C, eds. Immunobiology of HSV Infection. Boca Raton, Fl: CRC Press, 1983.
31. Adler K, Buzby P, Bobrow M, Erickson T. Rapid DNA detection using fluoresscein-antifluorescein-based (FAF) ELOSA. Dupont Biotechn Update 1992; 7:13-5.
32. Köhler TH, Laßner D, Rost AK, Thamm B, Pustowait B, Remke H. Quantitation of mRNA by Polymerase Chain Reaction. Nonradioactive PCR Methods. Berlin: Springer 1995.
33. Clontech. Methods and Applications Book 3: Quantitative RT-PCR. 1996.
34. + T cell-mediated protective immunity against herpes simplex virus-2 challenge. J Immunol 1999; 162:2912-21.
35. Torres PF, Slegers TP, Peek R, van Rooijen N, van der Gaag R, Kijlstra A, de Vos AF. Changes in cytokine mRNA levels in experimental corneal allografts after local clodronate-liposome treatment. Invest Ophthalmol Vis Sci 1999; 40:3194-201.
36. Tumpey TM, Cheng H, Cook DN, Smithies O, Oakes JE, Lausch RN. Absence of macrophage inflammatory protein-1a prevents the development of blinding herpes stromal keratitis. J Virol 1998; 72:3705-10.
37. Delemarre FG, Kors N, van Rooijen N. Elimination of spleen and of lymph node macrophages and its difference in the effect on the immune response to particulate antigens. Immunobiology 1990; 182:70-8.
38. Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK. Recombinant interleukin 12 cures mice infected with Leishmania major. J Exp Med 1993; 177:1797-802.
39. Ferguson TA, Herndon JM. The immune response and the eye: the ACAID inducing signal is dependent on the nature of the antigen. Invest Ophthalmol Vis Sci 1994; 35:3085-93.
40. Streilein JW, Dana R, Ksander BR. Immunity causing blindness: five different path to herpes stromal keratitis. Immunol Today 1997; 18:443-9.
41. Ksander BR, Hendricks RL. Cell-mediated immune tolerance to HSV-1 antigens associated with reduced susceptibility to HSV-1 corneal lesions. Invest Ophthalmol Vis Sci 1987; 28:1986-93.
42. Janeway CA, Travers P. Immunologie, 2nd edn. Heidelberg: Spektrum, Akademischer Verlag, 1997.
43. Van Rooijen N. Macrophages as accessory cells in the 'in vivo' humoral immune response: from processing of particulate antigens to regulation of suppression. Sem Immunol 1992; 4:237-45.
44. Wijburg OLC, Heemskerk MHM, Boog CJP, van Rooijen N. Role of spleen macrophages in innate and acquired immune response against mouse hepatitis virus strain A59. Immunology 1997; 92:252-8.
45. Slegers TP, Torres PF, Broersma L, van Rooijen N, van Rij G, van der Gaag R. Effect of macrophage depletion on immune effector mechanism during corneal allograft rejection in rats. Invest Ophthalmol Vis Sci 2000; 41:2239-47.
46. Snapper CM, Mond JJ. Towards a comprehensive view of immunoglobulin class switching. Immunol Today 1993; 15:15-7.